Venture Capital Investors

KHAN Technology Transfer Fund

KHAN Technology Transfer Fund invests in innovation by backing technology startup companies.

Venture Investor Overview

Contact Information

Background Information

Overview

KHAN Technology Transfer Fund I (KHAN-I) is an early-stage life sciences venture fund with � 70 millions under management. Our mission is to create value through cooperative drug development partnerships with academic innovators in Europe. KHAN-I focuses on first-in-class therapies for attractive markets with a high unmet medical need.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

2/7/2023

Transaction History

Our records indicate that KHAN Technology Transfer Fund invested in the VC transactions listed below. Dollar amounts are for the entire raise, which may include other investors.

Investor Contacts

Title

Name

Email & Social

Co-Founder

Johannes Bange

        

Chief Financial Officer

Michael Hamacher

        

Managing Director

Bert Klebl

        

Managing Director

Peter Nusbaumer

        

Funds

No fund closings have been recorded for this company.

Portfolio Companies

KHAN Technology Transfer Fund has invested in only one tech company, according to our database records. If we are missing a portfolio company, please let us know.

Browse more venture capital investors:

Khadjavi Capital Partners | Kharafi Global

Share this article

About Our VC & M&A Database

The venture capital investor data above is provided by VentureDeal.com, a market leader in private equity transaction data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary